Scribe Therapeutics Inc. (SCTX)
Nasdaq: SCTX · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Who runs Scribe Therapeutics Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Oakes Benjamin L.
President, CEO. First filing Jul 2026, latest Jul 27, 2026, 0 filings in all.
Officers reporting now
3
of 11 people with a filing in the last fifteen months
Directors reporting now
8
11 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Oakes Benjamin L. | President, CEO | Jul 2026 | Jul 27, 2026 | none |
| Parrot David | Chief Financial Officer | Jul 2026 | Jul 27, 2026 | none |
| Lucas Svetlana | Chief Business Officer | Jul 2026 | Jul 27, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gordon Carl L | director | Jul 2026 | Jul 29, 2026 | none |
| Orbimed Advisors LLC | director | Jul 2026 | Jul 29, 2026 | none |
| Orbimed Capital Gp Viii LLC | director | Jul 2026 | Jul 29, 2026 | none |
| Aghazadeh Behzad | director | Jul 2026 | Jul 28, 2026 | none |
| Avoro Capital Advisors LLC | director | Jul 2026 | Jul 28, 2026 | none |
| Avoro Ventures LLC | director | Jul 2026 | Jul 28, 2026 | none |
| Bleharski Joshua | director | Jul 2026 | Jul 27, 2026 | none |
| Watson James Dean | director | Jul 2026 | Jul 27, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ah Bio Fund II, L.P. | 10% owner | Jul 2026 | Jul 29, 2026 | none |
| Ah Bio Fund III, L.P. | 10% owner | Jul 2026 | Jul 29, 2026 | none |
| Ah Equity Partners Bio II, L.L.C. | 10% owner | Jul 2026 | Jul 29, 2026 | none |
| Ah Equity Partners Bio III, L.L.C. | 10% owner | Jul 2026 | Jul 29, 2026 | none |
| Andreessen Marc L | 10% owner | Jul 2026 | Jul 29, 2026 | none |
| Doudna Jennifer A | 10% owner | Jul 2026 | Jul 29, 2026 | none |
| Horowitz Benjamin A | 10% owner | Jul 2026 | Jul 29, 2026 | none |
| Staahl Brett | 10% owner | Jul 2026 | Jul 28, 2026 | none |
| Eli Lilly & Co | 10% owner | Jul 2026 | Jul 23, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.